On the other hand, those who develop T2DM at lower BMI may have (i) limited storage capacity or disordered adipose tissue function, (ii) varied susceptibility to toxic lipid metabolites, and (iii) failure to increase β-cell mass appropriately during adipose tissue expansion and increased demand on insulin [15,29,30]. The gene discussed is INS; the disease is type 2 diabetes mellitus.